Rashtriya Newsflash

Persistent Epithelial Defect Clinical Trial Pipeline Gains Momentum: 5+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

Persistent Epithelial Defect Clinical Trial Pipeline Gains Momentum: 5+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Persistent Epithelial Defect Pipeline Insights 2026” report provides comprehensive insights about 5+ Persistent Epithelial Defect Companies and 5+ pipeline drugs in the Persistent Epithelial Defect pipeline landscape. It covers

Read Full Article

Digital Wound Measurement Devices Market Shows Strong Growth Potential, Expected to Reach USD 565.83 Million by 2032, According to DelveInsight Digital Wound Measurement Devices Market

Digital Wound Measurement Devices Market Key Digital Wound Measurement Devices Companies are MolecuLight Inc., Wound Matrix Inc., Kent Imaging Inc., ARANZ Medical Limited, WoundVision LLC., Stryker, eKare Inc., Net, Perceptive

Read Full Article

BPL-003 Sales Forecast to 2034 Signals Transformational Growth in Treatment-Resistant Depression Market Driven by Rapid-Acting Psychedelic Innovation | DelveInsight

BPL-003 Sales Forecast The global neuropsychiatry landscape is undergoing a paradigm shift, and at the center of this transformation is BPL-003, a next-generation intranasal psychedelic therapy poised to redefine the

Read Full Article

Myositis Pipeline Gains Strong Momentum with 45+ Therapies and 40+ Companies Advancing Next-Generation Autoimmune Treatments | DelveInsight

Myositis Clinical Trial Key Myositis companies such as Pfizer, Galapagos NV, Fate Therapeutics, Bristol-Myers Squibb, Gilead Sciences, and CRISPR Therapeutics are spearheading innovation with advanced biologics, small molecules, and cell-based

Read Full Article

Traumatic Brain Injury Pipeline Enters a New Era of Innovation with 20+ Companies and 22+ Therapies Targeting Neuroprotection and Regeneration | DelveInsight

Traumatic Brain Injury Clinical Trial Key Traumatic Brain Injury Companies are Oragenics, Inc., SHINKEI Therapeutics, Inc., AlzeCure, Algernon Pharmaceutical, Mitochon

Read Full Article

Phase 3 EMN24 IsKia Study: Quadruplet Isa-KRd Regimen Significantly Improves MRD Negativity in Newly Diagnosed Multiple Myeloma | DelveInsight’s Perspective on Treatment Paradigm Shift

Phase 3 EMN24 IsKia Study: Quadruplet Isa-KRd Regimen Significantly Improves MRD Negativity in Newly Diagnosed Multiple Myeloma The EMN24 IsKia

Read Full Article

Breakthrough in Lupus Brain Fog Treatment: Vanderbilt Health and Evergreen Therapeutics Report Success in Phase 2 ClearMEMory Trial for EG501 | DelveInsight’s Perspective

Vanderbilt Health and Evergreen Therapeutics Report Success in Phase 2 ClearMEMory Trial for EG501 The Phase 2 ClearMEMory trial provided

Read Full Article

Satellite Payload Market to Reach USD 27.23 Billion by 2031 Driven by LEO Constellations, Software-Defined Payloads – Mordor Intelligence

Satellite Payload Market Mordor Intelligence has published a new report on the satellite payload market, offering a comprehensive analysis of

Read Full Article

Pharmacovigilance and Drug Safety Software Market Set to Reach USD 309.03 Million by 2031 Driven by Cloud Adoption

Mordor Intelligence has published a new report on the pharmacovigilance and drug safety software market, offering a comprehensive analysis of

Read Full Article

CNG and LPG Vehicle Market to Reach USD 10.7 Billion by 2031 with Expanding Refueling Networks and Strong Policy Support – Mordor Intelligence

CNG and LPG Vehicle Market Mordor Intelligence has published a new report on the CNG and LPG vehicle market, offering

Read Full Article